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Abstract
Introduction The ideal surgical treatment for pulmonary
metastasectomy remains controversial. Minimally invasive
surgery may offer advantages for quality of life outcomes,
with equivalent oncologic long-term results. The purpose
of our study was to confirm the validity of the thoraco-
scopic approach for pulmonary metastasectomy.
Methods We retrospectively reviewed 164 patients who
underwent 212 lung metastasectomies from January 2000
to December 2010. Complete curative pulmonary resec-
tions were performed in 159 (96.95 %) cases; 126 patients
developed lung metastases from epithelial tumors: 28 from
sarcoma, 7 from melanoma, and 3 from germ cell tumors.
The mean disease-free interval (DFI) was 38.75 months.
Fifty-four patients underwent a major VATS resection (53
thoracoscopic lobectomies and 1 pneumonectomy), and
110 patients underwent a wedge resection/segmentectomy.
Lymph node sampling was performed in 117 cases.
Results After a mean follow-up of 38 months, 87 patients
(53 %) had died. All resection margins were tumor-free at
final pathological examination. Multivariate analysis not
confirmed in our series a better prognosis for patients with
a particular histologic type and also DFI, age, number of
metastases, and type of surgery did not statistically influ-
ence long-term survival.
Conclusions Thoracoscopic surgery is an acceptable
procedure, safe and efficacious, with a 5-year overall sur-
vival that is equivalent to open surgery.
Keywords Pulmonary metastasis  Surgical resection 
VATS surgery  Morbidity  Minimally invasive 
CT scan technology
In recent years, lung metastases have been considered an area
of interest in many discussions between surgeons to identify
the best surgical approach [1]. An important study that
assessed the long-term results of pulmonary metastasectomy
was based on the International Registry of Lung Metastases
[2]. This large registry study revealed that complete resect-
ability, disease-free interval (DFI), and number of metasta-
ses were independent prognostic factors. Today, the majority
of surgeons prefer metastasectomy by open approach to
achieve bimanual lung palpation and to find and resect
undetected lesions [3, 4]. In fact, the reliance on computed
tomographic (CT) scanning to identify all pulmonary
metastases has been criticized [5], and many surgeons prefer
an open surgical approach. However, latest generation of CT
scanners is superior for the detection of metastatic pulmon-
ary nodules [6]; however, the clinical significance of these
nonimaged, resected malignant nodules is unknown, and it is
unclear whether the resection of these nodules improves
survival. Based on these data, others surgeons use video-
assisted thoracoscopic surgery (VATS) or robotic techniques
for pulmonary metastasectomy, saving the patient the
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morbidity of thoracotomy and offering advantages in quality
of life, probably with equivalent oncologic outcomes.
We started to perform VATS surgery in 1992 for the
treatment of all the thoracic diseases, and thoracoscopic
surgery had been favorably performed on patients who had
a solitary or multiple lesions. Generally, the pulmonary
metastasis was resected by pulmonary wedge resection,
when it was located in the periphery of the lung, and by
segmentectomy or lobectomy, when it was deep in the
parenchyma [7, 8].
In this study, performed in a single-center in the past
10 years, we review our experience in the thoracoscopic
surgical approach of lung metastases to evaluate whether a
less invasive approach is advisable in these patients, in
terms of resectability, long-term survival, and perioperative
course.
Patients and methods
We retrospectively reviewed 164 patients who underwent
to 212 thoracoscopic lung metastasectomies with curative
intent from January 2000 to December 2010 at the Tho-
racic Surgery Unit of ASL Ravenna, Ravenna, Italy, and
data were retrieved from individual medical records. All
patients included in the analysis had the following criteria:
the primary tumor is controlled (or controllable); there is
no other distant disease; complete resection of pulmonary
lesions is achievable with adequate pulmonary reserve; and
there are no effective medical therapies. Surgeries per-
formed for incomplete resection, biopsy-only, and/or other
diagnostic purpose were excluded.
Patients were considered eligible for curative surgery on
the basis of traditional staging with chest radiograph,
bronchoscopy, and thoracic/abdominal/brain CT. All 164
patients were investigated by CT scan, performed not later
than 30 days from the surgery, and 84 patients also were
evaluated by positron emission tomography (PET)/CT with
fluorodeoxyglucose.
DFI was defined as the time between treatment of the
primary tumor and the diagnosis of metastases. Ninety-
seven patients had a single-lung metastasis and 67 had
multiple lesions. We had three groups with different
number of lesions (Table 1).
We performed a total of 212 thoracoscopic metastasecto-
mies with 54 thoracoscopic lobectomy and 158 thoracoscopic
wedge resections/segmentectomy. Lymph node sampling
was obtained in 117 cases.
Surgical technique
All patients were operated on under general anesthesia with
double-lumen endotracheal intubation. All were positioned
in the lateral decubitus and in most cases, three ports were
sufficient to achieve the thoracoscopic resection: one port
for a 10-mm, 30 thoracoscope and two working ports for
endoscopic instruments (endoscopic stapler or ultrasonic
dissector). For major pulmonary resections, a utility mini-
thoracotomy (4–5 cm) without rib spreader was added. All
specimens were placed in an endoscopy bag and retrieved
through anterior port or the minithoracotomy [7, 8].
Statistical analysis
Patient characteristics are reported as means ± standard
deviations or n (%), as appropriate. Continuous variables of
patients with discordance and those without were com-
pared with independent t tests. The chi-squared or Fisher’s
exact test was used for categorical variables.
Overall survival (OS) was defined as the time from date
of surgery to death due to any cause. The Kaplan-Meier
method was used to estimate survival curves.
Univariate and subsequent multivariate binary logistic
regression analyses were performed to identify independent
factors. Hazard ratios (HRs) and corresponding 95% confi-
dence intervals (CIs) also are indicated. A two-sided P value
\0.05 was considered significant. All statistical analyses
were performed with the STATA software (version 11.1;
Texas USA).
Results
After a mean follow-up of 38 months, 77 (47 %) patients
are alive (Fig. 1). Complete curative resection was
obtained in 159 patients (96.95 %; Fig. 2).
One hundred patients (61 %) were men and 64 (39 %)
were women. Mean age was 64 years (±14.4). Primary
tumors were classified into four histological categories:
epithelial, sarcoma, melanoma, and germ cell tumors. A
total of 126 (77 %) patients developed metastases from
epithelial tumors, 28 (17 %) developed from sarcoma, 7
(4 %) developed from melanoma, and 3 (1.8 %) from germ
cell tumors (Table 1).
A total of 143 patients (87 %) underwent a single proce-
dure (including six cases of bilateral planned thoracoscopic
surgery within 30 days), and 21 patients (13 %) underwent
multiple metastasectomies (redo surgery for 8 patients or
contralateral surgery but later than 30 days for 13 patients).
We performed a total of 212 metastasectomies with thoraco-
scopic lobectomy in 53 patients and thoracoscopic pneumo-
nectomy in 1:136 wedge resections and 22 segmentectomies.
Nodal metastases were discovered in 20 cases (12 %); in
95 patients (58 %) nodes were negative. Node sampling was
not performed in 49 (30 %) patients. All resection margins
were tumor-free at final pathological examination.
Surg Endosc (2013) 27:1938–1944 1939
123
Table 1 Clinical characteristics
Predictor variables Overall (%) Alive (%) Death (%) P value
No. of patients 164 (100) 77 (46.95) 87 (53.05)
Sex
Male 100 (60.98) 48 (62.34) 52 (59.77) 0.7
Female 64 (39.02) 29 (37.66) 35 (40.23)
Age (mean ± SD) 64.17 ± 14.4 65.18 ± 13.98 63.27 ± 14.78 0.4
Histology
Sarcoma 28 (17.07) 11 (14.29) 17 (19.54) 0.2
Melanoma 7 (4.27) 4 (5.19) 3 (3.45)
Germ cell tumors 3 (1.83) 0 3 (3.45)
Epithelial 126 (76.83) 62 (80.52) 64 (73.56)
Colorectal 99 (78.57) 51 (82.26) 48 (75) 0.4
Breast 14 (11.11 5 (8.06) 9 (14.06)
Urothelial 3 (2.38) 1 (1.61) 2 (3.13)
Gynecological 2 (1.59) 2 (3.23) 0
Head-neck 8 (6.35) 3 (4.84) 5 (7.81)
Metastasis
1 97 (59.15) 44 (57.14) 53 (60.92) 0.3
2–3 50 (31.71) 28 (36.36) 24 (27.59)
4? 17 (9.15) 5 (6.49) 10 (11.49)
Surgery
Wedge/segmentectomy 136 (68) 55 (71.43) 55 (63.22) 0.2
Lobectomy 54 (32.93) 22 (28.57) 32 (36.78)
Procedure
Single procedure 143 (87.2) 69 (89.91) 74 (85.06) 0.4
Redo 8 (10.39) 13 (14.94) 21 (12.8)
Nodal status
Negative 95 (57.93) 51 (66.23) 44 (50.57) 0.09
Positive 20 (12.2) 6 (7.79) 14 (16.09)
Unknown 49 (29.88) 20 (25.97) 29 (33.3)
Fig. 1 Patients survival Fig. 2 Completeness of resection
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We had no cases of local recurrence, defined as a tumor
relapse at the site of the staple line. There were no intra-
operative complications in any of the 164 VATS patients.
The most common postoperative minor complications were
arrhythmia, hydrothorax, pleural effusion, and air leak
(Table 2).
Major complications occurred in four patients (2.4 %);
two patients developed hemothorax (requiring one tho-
racoscopic drainage and the other a thoracotomy), two
patients developed respiratory insufficiency and required
admission to intensive care unit for 3 and 3 days. There
were no postoperative deaths.
Conversion from VATS to thoracotomy occurred in 10
patients (6.5 %): four cases for pleural adhesion, four cases
of diffuse metastatic disease, and two for mediastinal and
hilar adenopathies.
There were no postoperative deaths, and the mean
hospital stay after surgery was 5 days (interquartile range
4–8). One hundred twenty-three patients were admitted to
the intensive care unit after the surgery with a mean stay of
1 day (range 1–5 days).
Multivariate analysis (Table 3) not confirmed in our
series that patients with a particular histologic type (pri-
mary tumor histology, Fig. 3) had a better prognosis (for
example, patients with melanoma or sarcoma in our series
had no a worse prognosis than those with epithelial
Fig. 3 Histology
Fig. 4 Disease Free Interval
Table 2 Minor postoperative complications
Arrhythmia 10
Pleural effusion 7
Prolonged air leak 7
Transfusion 6
Postobstructive pneumonia 3
Table 3 Multivariate analysis for overall survival after pulmonary
metastectomy
Variable HR (95% CI) P
Resection
R0 0.53 (0.16–1.71) 0.29
R1 1
DFI
Simultaneous (mo) 1.25 (0.62–2.52) 0.52
1–12 1.00
12–36 0.77 (0.4–1.46) 0.43
[36 1.06 (0.6–1.849 0.83
Sex
Men 1
Women 0.81 (0.51–1.28) 0.38
Age (years)
\60 1
60–69 0.61 (0.22–1.67) 0.33




2–3 0.74 (0.44–1.22) 0.24
[4 1.46 (0.68–3.12) 0.32
Histology
Epithelial 1
Sarcoma 0.9 (0.5–1.62) 0.74
Melanoma 1.46 (0.35–6.07) 0.59
Germ cell 1.11(0.34–3.61) 0.85
Surgery
Wedge resection 1
Lobectomy/segmentectomy 0.97 (0.61–1.53) 0.46
Nodal status
Negative 1
Positive 1.37 (0.74–2.53) 0.3
Unknown 1.13 (0.68–1.88) 0.63
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tumors). DFI (Fig. 4), nodal status (Fig. 5), epithelial
tumors (Fig. 6), number of metastesectomies (Fig. 7), and
number of procedures (Fig. 8) did not statistically influence
long-term survival.
Moreover, patients who underwent anatomical pul-
monary resection (segmentectomy/lobectomy) compared
with those who underwent wedge resection did not show
any significant difference in long-term survival (Fig. 9).
Discussion
The surgical approach to lung metastases remains highly
variable. The choice of approach to pulmonary resection
depends more on surgical training and personal conviction
than on scientific basis. Certainly, the surgeon who oper-
ates on patients affected by advanced disease and history of
pulmonary metastases has a moving target in terms of
surgical approaches and systemic therapies [9]. Some
authors prefer lung palpation during the operation to find
and resect undetected lesions. According to previous
reports, approximately 20 % of additional malignant nod-
ules could be detected by manual palpation than by pre-
operative chest CT scan, but the clinical significance of
Fig. 5 Nodal Status
Fig. 6 Epithelial tumors
Fig. 7 Number of metastasectomies
Fig. 8 Number of surgeries
Fig. 9 Surgery
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these nonimaged, resected, malignant nodules is unknown
[10, 11]. Other surgeons prefer minimally invasive surgery
to perform pulmonary metastasectomy and VATS proce-
dure can be performed with less morbidity and faster
recovery. Potential advantages of the minimally invasive
approach include smaller incisions, less postoperative pain,
shorter length of stay, fewer adhesions at reoperation, and
better compliance with adjuvant therapies if indicates. The
initial data indicate that survival rates do not seem to sig-
nificantly differ if the patients undergo VATS or open
surgery [12–14]. Currently, there is no scientific evidence
that resection of pulmonary metastases at the time they
become radiographically apparent is any less efficacious
than open procedures that remove all nodules, benign and
malignant, before their radiologic identification. Besides, in
open surgery there is the added morbidity of resecting
benign nodules (approximately 50 % of nodules palpated),
and the complete resection of all palpable metastatic nod-
ules by open surgery is a not a complete biologic resection
of all metastatic deposits [15].
Based on our experience, we believe that a surgeon with
a large experience in VATS surgery has the ability to
achieve complete resection; the ability of complete surgical
excision of the metastatic nodules has been shown to be the
most significant prognostic factor in the literature. This
present study emphasizes the concept that in patients with
lung metastases, the biology of the tumor is more important
than the strategy of resection. In our thoracoscopic surgical
experience, complete curative pulmonary resections were
performed in 159 (96.95 %) cases and all resection margins
were tumor-free at final pathologic examination. We had
no a local recurrence (a tumor relapse at the staples site),
and after a mean follow-up of 38 months, 77 (47 %)
patients are alive and the overall survival is comparable
with that of conventional open surgery. However, multi-
variate analysis in our study failed to identify any param-
eter that could statistically influence the long-term survival.
The recent development of multidetector row CT tech-
nology has made it possible to detect smaller-sized pul-
monary nodules with excellent resolution during a single
breath hold and to reconstruct CT images at a thickness of
1 mm. This new CT technology could improve the accu-
racy of CT scan in the detection of lung metastases and
could be a substitute for manual palpation in pulmonary
metastasectomy.
In case of recurrence of disease, a minimally invasive
approach may be efficaciously repeated with low morbidity
in the same patient, with a long-term outcome that is
comparable with that after resection by thoracotomy.
However, there is no evidence to suggest that the timing of
resection of nodules that would be missed at thoracoscopic
resection (which are usually\5 mm in diameter) is critical
to the final outcome and, as we know, second resection do
not adversely affect the overall outcome of patients with
metasynchronous detected lesions. Thoracoscopic surgery
may be favored in selected patients (for example those with
a long DFI, or with a peripherally located nodule, or with
several comorbidities, etc.), and we believe that the patient
needs to be aware of all surgical options, with their
advantages and limitations, and the best approach should
be selected together with the surgeon.
For the future, there is need for prospective, clinical
trials, performed in a multicenter setting, to obtain ade-
quate answers about the best surgical approach for these
patients, perhaps even with new CT technology use.
Besides, is very important for the new generations of tho-
racic surgeons obtain an adequate training in thoracoscopic
surgery, to ensure experience and familiarity also with a
minimally invasive pulmonary metastasectomy.
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